# Cystic Fibrosis Withdrawal of Inhaled Steroids Evaluation Study (CF WISE Study)

> **NCT00220259** · NA · COMPLETED · sponsor: **Royal Brompton & Harefield NHS Foundation Trust** · enrollment: 240 (—)

## Conditions studied

- Cystic Fibrosis

## Interventions

- **DRUG:** Fluticasone or placebo

## Key facts

- **NCT ID:** NCT00220259
- **Lead sponsor:** Royal Brompton & Harefield NHS Foundation Trust
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-05
- **Primary completion:** —
- **Final completion:** 2005-02
- **Target enrollment:** 240 (—)
- **Last updated:** 2005-11-08

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00220259

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00220259, "Cystic Fibrosis Withdrawal of Inhaled Steroids Evaluation Study (CF WISE Study)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00220259. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
